Capital International Investors
WGS icon

Capital International Investors’s GeneDx Holdings WGS Stock Holding History

Capital International Investors’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-324,588
Closed -$20.8M – 482
2026
Q1 		$20.8M Buy
324,588
+41,340
+15% +$3.77M ﹤0.01% 386
2025
Q4 		$36.8M Buy
283,248
+182,964
+182% +$25.1M 0.01% 378
2025
Q3 		$10.8M Buy
+100,284
New +$10.9M ﹤0.01% 402

Other funds holding WGS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $1.1B AUM 171.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Capital International Investors's WGS Position: Q2 2026 in Review

Capital International Investors sold out of GeneDx Holdings (WGS) in Q2 2026, closing a stake of 324,588 shares — an estimated $20.8M sold.

Capital International Investors first reported a position in WGS in Q3 2025 and held it in 3 quarters. The position peaked at $36.8M in Q4 2025. 151 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Capital International Investors reported no remaining GeneDx Holdings position as of Q2 2026 after selling out during the quarter.
  • Capital International Investors sold 324,588 GeneDx Holdings shares in Q2 2026, an estimated $20.8M.
  • Capital International Investors first reported a position in GeneDx Holdings in Q3 2025 and held it in 3 quarters.
  • Capital International Investors's GeneDx Holdings position peaked at $36.8M in Q4 2025.
  • 151 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Capital International Investors's 13F filing for Q2 2026, filed 12 Aug 2026.